A STEMI heart attack is the most serious kind because one of the heart’s main supply arteries is completely blocked. After ...

CorWave today announced the world's first human implantation of its left ventricular assist device (LVAD) in Australia.

Medtronic receives CE Mark for VitalFlow™ ECMO System, ushering in a new era of critical care in EuropeMedtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of ...

An Australian hospital has become the first in the world to implant a revolutionary device considered a “quantum leap” in ...

Mesoblast shows promise with FDA progress and a strong pipeline, but limited data and execution risks persist. Learn why MESO ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case ...

The Central Military Hospital 108 and Germany’s Hannover Medical School (MHH) will step up cooperation in high-quality ...

Resumption of CARMAT shares trading starting July 2, 2025, at stock market opening Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial ...

Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

Laws vary sometimes even from city to city when it comes to keeping the power on for life support customers who make late ...